Healthcare actual property entered 2026 with robust fundamentals intact, together with excessive occupancy, predictable earnings streams and mission-critical tenancy, Companion Valuation Advisors mentioned in its newly issued Q1 2026 Healthcare & Life Sciences Market Report. These traits have continued to draw investor consideration, significantly as broader market uncertainty persists.
Transaction exercise, whereas measured, has gained momentum because the second half of 2025 and continues into early 2026. Buyers are re-engaging with a disciplined strategy, prioritizing high-quality property with secure money stream and long-term demand drivers. Portfolio-level transactions have additionally re-emerged this 12 months.
“As pricing has turn into clearer, we’re seeing capital re-engage with extra self-discipline,” mentioned Erik Hill, managing director and Nationwide Follow Lead for Healthcare & Life Sciences at Companion Valuation Advisors. “Buyers are targeted on high quality, sturdy money stream and long-term demand, which is driving a extra secure and intentional transaction setting in healthcare actual property.”
